It is unclear when a generic version of dutasteride (Avodart) will become available. The first patent has already expired, which means it's likely that the drug is protected by a different patent that hasn't expired yet. Until a true generic becomes available, you should not buy any drug on the Internet claiming to be "generic dutasteride."
Generic for Dutasteride: An OverviewDutasteride (Avodart®) is a prescription medication that has been licensed to treat an enlarged prostate. Enlarged prostate is also known as benign prostatic hyperplasia, benign prostatic hyperplasia, or BPH.
Dutasteride is manufactured by GlaxoSmithKline. It is currently under the protection of a patent that prevents any generic dutasteride from being manufactured in the United States. Yet, if you search the Internet for "generic dutasteride," you may find a number of companies selling it.
The fact is that these medicines are fake, substandard, and potentially dangerous. There may be a generic dutasteride available from another country, but there is really no way of knowing if you are getting genuine dutasteride or not. You should not buy any generic dutasteride until there is an approved generic available.
When Will Generic Dutasteride Be Available?
The first patent for dutasteride expired in 2013. Yet, no generic versions are available. This suggests that another patent, set to expire in November 2015, is still protecting the drug from generic competition. This is the earliest possible date that a generic version of dutasteride could become available.
However, there are other circumstances that could come up to extend the exclusivity period of dutasteride beyond 2015. These circumstances could include such things as other patents for specific dutasteride uses or lawsuits. Once dutasteride goes off patent, there may be several companies that manufacture a generic dutasteride drug.